Trial Profile
A Demonstration Project of HIV Pre-exposure Prophylaxis (PrEP) With Tenofovir DF/Emtricitabine (TDF/FTC Among Female Sex Workers in Dakar, Senegal
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 05 Nov 2021
Price :
$35
*
At a glance
- Drugs Emtricitabine/tenofovir disoproxil fumarate (Primary)
- Indications HIV infections
- Focus Therapeutic Use
- 12 Apr 2018 Status changed from recruiting to completed.
- 29 Aug 2017 New trial record
- 26 Jul 2017 Results (n=271 enrolled between Jul 2015 and Nov 2015) presented at the 9th International AIDS Society Conference on HIV Science